Tender Offer vs Secondary Sale: Key Differences Explained

A tender offer is a formal, company-facilitated process in which a buyer (often a new investor or the company itself in a buyback) offers to purchase shares from existing shareholders at a set price. Tender offers are structured events with defined terms, timelines, and eligibility criteria. Startup tender offers are typically triggered by late-stage investors (pre-IPO) who want to buy existing shares from founders, early employees, or angels. The company coordinates the process, sets the price, and determines which shareholders can participate. Tender offers provide liquidity at scale and are regulated events — particularly for companies with 2,000+ shareholders. Anyone comparing secondary sales vs tender offers in venture-backed companies should start with who runs the process: in a tender offer, the company does. The company (often with a new investor funding the purchases) sets a single price for everyone — typically anchored to a recent financing round or a fresh 409A valuation — defines who is eligible to participate (commonly employees past a vesting or tenure threshold, sometimes early investors as well), sets per-person caps on how much can be sold, and keeps the offer open for a defined election window. Because the company controls documentation and settlement, it can also handle tax withholding at closing, which matters enormously for employees whose proceeds are treated partly as compensation. The structure exists precisely because it protects employees from mispricing and protects the company from a chaotic, one-off transfer market in its own stock.

A secondary sale is a direct transaction in which one shareholder sells shares to another buyer — without the company necessarily being involved or coordinating the process. Secondary sales can be bilateral (one seller, one buyer) or intermediated through platforms like Forge, Nasdaq Private Market, or Carta. Secondary sales are less formal than tender offers. They require company approval (right of first refusal, transfer restrictions in charter) but don't require the company to run a process. They are faster and more flexible but limited in scale — typically individual transactions rather than company-wide liquidity events. A bilateral secondary, by contrast, is self-arranged: the shareholder finds their own buyer — directly, through a broker, or on a platform — and negotiates their own price. Eligibility is governed not by an invitation but by the company's transfer restrictions: nearly every venture-backed company's bylaws or stock agreements include a right of first refusal (ROFR), and many require outright board consent before any transfer. That means the company can match the buyer's price and take the shares itself, or simply decline the transfer. Pricing is whatever the two parties agree, which cuts both ways — sophisticated sellers in hot companies sometimes beat the last round price, while employees selling without market visibility commonly leave money on the table. All legal costs, documentation, and tax planning fall on the seller.

Tender offers are the right tool for company-wide liquidity events at scale. Secondary sales work for individual transactions. As startups stay private longer, both mechanisms are increasingly important for employee retention and founder financial planning. If you are managing a late-stage company, understand both — and have a liquidity strategy that goes beyond 'wait for the IPO.' For investors rather than employees, the calculus differs: institutional holders selling fund positions care less about withholding and more about price discovery and speed, so bilateral secondaries and structured secondary funds do most of that volume, while tender offers remain primarily an employee-liquidity tool. Early-stage founders should understand both, but the operational takeaway is simple — put clean transfer restrictions and a ROFR in place early, so that when liquidity demand arrives you can channel it into an orderly process instead of policing one-off sales.

A startup preparing for an IPO in 18 months raises a $100M growth round. As part of the deal, the lead investor structures a $20M tender offer, allowing employees with >4 years of service to sell up to 15% of vested shares at the round price. This provides employee liquidity without requiring an IPO. Separately, the CEO sells $5M of their personal shares directly to a family office — a secondary sale that runs concurrently but is a separate bilateral transaction. Now run the numbers from the employee's side. Suppose the same employee holds 20,000 vested non-qualified stock options with a $2.00 strike price, and the company tenders at $10.00 per share. If she exercises and sells all 20,000 in the tender, her gross proceeds are 20,000 × $10.00 = $200,000, her exercise cost is 20,000 × $2.00 = $40,000, and the $160,000 spread is typically taxed as ordinary compensation income with payroll withholding taken at closing — the company handles it, and she nets the remainder without filing surprises. If instead she had exercised those options two years earlier and then sold the shares in a bilateral secondary at the same $10.00, the appreciation above the value at exercise would generally be capital gain — potentially long-term — but she would have needed the cash and the risk appetite to exercise early, and the company could still have blocked or ROFR'd the transfer. Same shares, same price, materially different process, eligibility, and tax outcome.